Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Calaway

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
European Urology|September 7, 2023
Re: Nima Nassiri, Giovanni Cacciamani, Inderbir S. Gill. Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor. Eur Urol. 2023;84:517-518Laura E Davis, Adam Calaway, Laura Bukavina
European Urology|January 22, 2025
Re: Robert Huddart, Shaista Hafeez, Clare Griffin, et al. Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomized Controlled Trial. Eur Urol 2025;87:60-70Laura E Davis, Adam Calaway, Jonathan Shoag
European Urology|May 13, 2026
Re: Kitamura et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection (JCOG1019). Eur Urol 2026. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008Spyridon P Basourakos, Jonathan Shoag, Adam Calaway
The Urologic Clinics of North America|November 21, 2020
Robotic Partial Nephrectomy: Update on TechniquesLaura Bukavina, Kirtishri Mishra, Adam Calaway, et al.
The Urologic Clinics of North America|June 26, 2026
Emerging Intravesical Therapies for Non-Muscle-Invasive Bladder CancerBetty Wang, Ilaha Isali, Adam Calaway, et al.
Journal of Cellular Immunology|December 23, 2024
Cytoreductive Nephrectomy Following Immunotherapy: Evolution, Pearls, and Pitfalls of TreatmentLaura E Davis, Adam Calaway, Eric A Singer, et al.
European Urology|June 16, 2024
Circulating Tumor DNA To Assess Minimal Residual Disease: Versatile, but How Valuable?Jason R Brown, Guru P Sonpavde, Adam Calaway, et al.
BJU International|July 25, 2012
Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomesDaniel Sagalovich, Adam Calaway, Abhishek Srivastava, et al.
European Urology Oncology|May 3, 2024
Association Between GLP1R Agonists and Prostate, Kidney, and Bladder CancersLaura Bukavina, Emma Helstrom, Christopher J D Wallis, et al.
Urolithiasis|May 7, 2025
Increased risk of upper tract urothelial carcinoma in patients with kidney stones: a large-scale analysis of the UK biobankHachem Ziadeh, Adam Calaway, Sanjay Gupta, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
European Urology|September 7, 2023
Re: Nima Nassiri, Giovanni Cacciamani, Inderbir S. Gill. Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor. Eur Urol. 2023;84:517-518Laura E Davis, Adam Calaway, Laura Bukavina
European Urology|January 22, 2025
Re: Robert Huddart, Shaista Hafeez, Clare Griffin, et al. Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomized Controlled Trial. Eur Urol 2025;87:60-70Laura E Davis, Adam Calaway, Jonathan Shoag
European Urology|May 13, 2026
Re: Kitamura et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection (JCOG1019). Eur Urol 2026. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008Spyridon P Basourakos, Jonathan Shoag, Adam Calaway
The Urologic Clinics of North America|November 21, 2020
Robotic Partial Nephrectomy: Update on TechniquesLaura Bukavina, Kirtishri Mishra, Adam Calaway, et al.
The Urologic Clinics of North America|June 26, 2026
Emerging Intravesical Therapies for Non-Muscle-Invasive Bladder CancerBetty Wang, Ilaha Isali, Adam Calaway, et al.
Journal of Cellular Immunology|December 23, 2024
Cytoreductive Nephrectomy Following Immunotherapy: Evolution, Pearls, and Pitfalls of TreatmentLaura E Davis, Adam Calaway, Eric A Singer, et al.
European Urology|June 16, 2024
Circulating Tumor DNA To Assess Minimal Residual Disease: Versatile, but How Valuable?Jason R Brown, Guru P Sonpavde, Adam Calaway, et al.
BJU International|July 25, 2012
Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomesDaniel Sagalovich, Adam Calaway, Abhishek Srivastava, et al.
European Urology Oncology|May 3, 2024
Association Between GLP1R Agonists and Prostate, Kidney, and Bladder CancersLaura Bukavina, Emma Helstrom, Christopher J D Wallis, et al.
Urolithiasis|May 7, 2025
Increased risk of upper tract urothelial carcinoma in patients with kidney stones: a large-scale analysis of the UK biobankHachem Ziadeh, Adam Calaway, Sanjay Gupta, et al.
Pageof 5